Does Pycnogenol Intensify the Efficacy of Acetylsalicylic Acid in the Inhibition of Platelet Function? in vitro experience

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 60, Issue , 2006, Pages 316-321

  Golański, Jacek ^a   Muchova, Jana ^b   Golański, Ryszard ^a   Durackova, Zdenka ^b   Markuszewski, Leszek ^a   Watała, Cezary ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

Author keywords

Acetylsalicylic Acid (ASA); Platelet inhibition; Pycnogenol

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; FLAVONOID; PYCNOGENOLS; UNCLASSIFIED DRUG;

ADULT; DRUG EFFECT; DRUG POTENTIATION; HUMAN; PHYSIOLOGY; REVIEW; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ADULT; ASPIRIN; BLOOD PLATELETS; DRUG SYNERGISM; FLAVONOIDS; HUMANS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RESEARCH SUPPORT, NON-U.S. GOV'T;

EID: 33846081156     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Araghi-Niknam M., Hosseini S., Larson D., Rohdewald P., Watson R.R.: Pine bark extract reduces platelet aggregation. Integr. Med., 2000; 2: 73-77
2. Cardinal D.C., Flower R.J.: The electronic aggregometer: A novel device for assessing platelet behavior in blood. J. Pharmacol. Methods, 1980; 3: 135-158
3. Demrow H.S., Slane P.R., Folts J.D.: Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation, 1995; 91: 1182-1188
4. Durackova Z., Krizkova L., Maruniakova A.: Biological activities of natural polyphenols (Pycnogenol and EGb761) and their interaction with Vitamin C and E. In: El hadrami I. (Ed.) Polyphenols communications 2002, Vol 2. Marrakech 2002; p. 315-316, Depot legal: 2002/1299
5. Eikelboom J.W., Hirsh J., Weitz J.I., Johnston M., Yi Q., Yusuf S.: Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation, 2002; 105: 1650-1655
6. Fitzpatrick D.F., Bing B., Rohdewald P.: Endothelium-dependent vascular effects of Pycnogenol. J. Cardiovasc. Pharmacol., 1998; 32: 509-515
7. Freedman J.E., Parker C. III, Li L., Perlman J.A., Frei B., Ivanov V., Deak L.R., Iafrati M.D., Folts J.D.: Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation, 2001; 103: 2792-2798
8. Golanski J., Golanski R., Iwaszkiewicz A., Chlopicki S., Gresner P., Watala C.: Resistance to aspirin in patients after coronary artery bypass grafting is transient. Impact on the monitoring of aspirin antiplatelet therapy. Ther. Drug Monit., 2005; 27: 484-490
9. Guerrero J.A., Lozano M.L., Castillo J., Benavente-Garcia O., Vicente V., Rivera J.: Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor. J. Thromb. Haemost., 2005; 3: 369-376
10. Gum P.A., Kottke-Marchant K., Welsh P.A., White J., Topol E.J.: A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J. Am. Coll. Cardiol., 2003; 41: 961-965
11. Helgason C.M., Tortorice K.L., Winkler S.R., Penney D.W., Schuler J.J., McClelland T.J., Brace L.D.: Aspirin response and failure in cerebral infarction. Stroke, 1993; 24: 345-350
12. Hertog M.G., Feskens E.J., Hollman P.C., Katan M.B., Kromhout D.: Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet, 1993; 342: 1007-1011
13. Jacobson K.A., Moro S., Manthey J.A., West P.L., Ji X.D.: Interactions of flavones and other phytochemicals with adenosine receptors. Adv. Exp. Med. Biol., 2002; 505: 163-171
14. Janssen K., Mensink R.P., Cox F.J., Harryvan J.L., Hovenier R., Hollman P.C., Katan M.B.: Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am. J. Clin. Nutr., 1998; 67: 255-262
15. Kim Y.S., Pyo M.K., Park K.M., Park P.H., Hahn B.S., Wu S.J., Yun-Choi H.S.: Antiplatelet and antithrombotic effects of a combination of ticlopidine and ginkgo biloba ext (EGb 761). Thromb. Res., 1998; 91: 33-38
16. Kottke Marchant K., Powers J.B., Brooks L., Kundu S., Christie D.J.: The effect of antiplatelet drugs, heparin, and preanalytical variables on platelet function detected by the platelet function analyzer (PFA-100). Clin. Appl. Thromb. Hemost., 1999; 5: 122-130
17. Kundu S.K., Heilmann E.J., Sio R., Garcia C., Davidson R.M., Ostgaard R.A.: Description of an in vitro platelet function analyzer-PFA-100. Semin. Thromb. Hemost., 1995; 21(Suppl 2): 106-112
18. Neiva T.J., Morais L., Polack M., Simoes C.M., D'Amico E.A.: Effects of catechins on human blood platelet aggregation and lipid peroxidation. Phytother. Res., 1999; 13: 597-600
19. Pace-Asciak C.R., Hahn S., Diamandis E.P., Soleas G., Goldberg D.M.: The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin. Chim. Acta, 1995; 235: 207-219
20. Patrono C., Coller B., FitzGerald G.A., Hirsh J., Roth G.: Platelet-active drugs: The relationships among dose, effectiveness, and side effects: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004; 126: 234S-264S
21. Pearson D.A., Paglieroni T.G., Rein D., Wun T., Schramm D.D., Wang J.F., Holt R.R., Gosselin R., Schmitz H.H., Keen C.L.: The effects of flavanol-rich cocoa and aspirin on ex vivo platelet function. Thromb. Res., 2002; 106: 191-197
22. Putter M., Grotemeyer K.H., Wurthwein G., Araghi-Niknam M., Watson R.R., Hosseini S., Rohdewald P.: Inhibition of smoking-induced platelet aggregation by aspirin and pycnogenol. Thromb. Res., 1999; 95: 155-161
23. Rechner A.R., Kroner C.: Anthocyanins and colonic metabolites of dietary polyphenols inhibit platelet function. Thromb. Res., 2005; 116: 327-334
24. Rein D., Paglieroni T.G., Wun T., Pearson D.A., Schmitz H.H., Gosselin R., Keen C.L.: Cocoa inhibits platelet activation and function. Am. J. Clin. Nutr., 2000; 72: 30-35
25. Rohdewald P.: A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. Int. J. Clin. Pharmacol. Ther., 2002; 40: 158-168
26. Schror K.: Aspirin and platelets: The antipletelet action of aspirin and its role in thrombosis treatment and prophylaxis. Semin. Thromb. Hemost., 1997; 23: 349-356
27. Son D.J., Cho M.R., Jin Y.R., Kim S.Y., Park Y.H., Lee S.H., Akiba S., Sato T., Yun Y.P.: Antiplatelet effect of green tea catechins: A possible mechanism through arachidonic acid pathway. Prostaglandins Leukot. Essent. Fatty Acids, 2004; 71: 25-31
28. Vita J.A.: Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am. J. Clin. Nutr., 2005; 81: 292S-297S
29. Watala C., Pluta J., Golanski J., Rozalski M., Czyz M., Trojanowski Z., Drzewoski J.: Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin. J. Mol. Med., 2005; 83: 148-158